Jeremy Silas

Jun 3, 2024 | mondaq.com | Scott Perlman |Jeremy Silas |Ora Nwabueze

The Federal Trade Commission's (FTC) push against private equity roll-ups has hit a snag. On May 14, 2024, US District Judge Kenneth Hoyt of the Southern District of Texas granted a motion to dismiss filed by Welsh, Carson, Anderson & Stowe (Welsh Carson), while denying the motion to dismiss filed by co-defendant US Anesthesia Partners (USAP).

May 30, 2024 | jdsupra.com | Scott Perlman |Jeremy Silas

[co-author: Ora Nwabueze]The Federal Trade Commission’s (FTC) push against private equity roll-ups has hit a snag. On May 14, 2024, US District Judge Kenneth Hoyt of the Southern District of Texas granted a motion to dismiss filed by Welsh, Carson, Anderson & Stowe (Welsh Carson), while denying the motion to dismiss filed by co-defendant US Anesthesia Partners (USAP).

Mar 11, 2024 | today.westlaw.com | Rachel J. Lamorte |Thomas V. Panoff |Daniel K. Storino |Jeremy Silas

(May 01, 2024) - Mayer Brown LLP attorneys Rachel Lamorte, Thomas Panoff, Daniel Storino and Jeremy Silas discuss an announcement by three federal regulators that they are looking into private equity's "increasing control over health care."•Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. •The public comment period is a good opportunity for private equity firms to weigh in.